Market Place
Sourcing Support
FDA’s June 2024 list of off-patent, off-exclusivity drugs sees rise in cancer, HIV treatments
This week PharmaCompass brings to you key highlights of the US Food and Drug Administration’s
After beef, India may ban gelatin capsules; GSK, Gilead’s HIV race heats up
This
week in Phispers, we bring you the latest twists in the GSK-Gilead rivalry over
HIV drugs. Indi
Chemical entities SHINE in the top 10 fastest-growing drugs of 2016
Global
pharmaceutical companies are increasingly focusing on the development of new
biologics. In fa
Top drugs by sales revenue in 2015: Who sold the biggest blockbuster drugs?
The year 2015 has gone down
in history as a record year for mergers and acquisitions in the pharmace
